Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy

NCT02446704 is registered in ClinicalTrials.gov with Zofia Piotrowska as lead sponsor.

NCT NCT02446704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02446704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy
Lead sponsor
Zofia Piotrowska
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 13, 2015
Completion date
December 31, 2023
Enrollment
66 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer